author-photo

Julie Barone

Sharp Memorial Hospital

13

Papers

92

Citations

Citation Trend

Filter By

Papers (10) Sort By

Journal Conference Others

Molecular profiles of genomically high risk ER+ HER2- breast cancer tumors classified as functionally basal or luminal B by the 80-gene signature.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PS14-11: Differential gene expression analysis and clinical utility of MammaPrint and BluePrint in male breast cancer patients

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Distinct molecular profiles of interval and screen-detected tumors in a real-world breast cancer registry.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Prospective phase II multicenter trial of ablation after breast lumpectomy added to treat (ABLATE) breast cancer without radiation.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A Prospective, Single Arm, Multi-site, Clinical Evaluation of a Nonradioactive Surgical Guidance Technology for the Location of Nonpalpable Breast Lesions during Excision.

2016 Annals of Surgical Oncology
Show All
- Source
- Cite
- Save
Citations (46)
Central review of discordant samples for microarray-based ER, PR, and HER2 and local IHC/FISH assessment worldwide from 827 patients.

2012 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
346 Comparison of Molecular Subtyping with BluePrint and MammaPrint to Local IHC/FISH Based Subtype Classification According to St Gallen 2011 in 133 Breast Cancer Patients

2012 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Comparison of MammaPrint and TargetPrint with clinical parameters in patients with breast cancer: Findings from a prospective U.S. cohort.

2011 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
P5-11-09: High Concordance for Microarray Based Determination of ER, PR and HER2 Receptor Status and Local IHC/FISH Assessment Worldwide in 749 Patients.

2011 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
P3-04-06: Comparison of MammaPrint, BluePrint, and TargetPrint with Clinical Parameters in Patients with Breast Cancer: Findings from a Prospective United States Cohort.

2011 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)